SCHEMBL6382007

SCHEMBL6382007

COc1ccc2c(OC)nc(N(C)C)cc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 5/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2A6 P11509 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
RAB9A P51151 2/20 0.40
TRPA1 O75762 1/20 0.40
LMNA P02545 2/20 0.38
APAF1 O14727 1/20 0.38
MAPT P10636 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
NCF1 P14598 1/20 0.38
KDM1A O60341 1/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP3A4 P08684 1/20 0.37
VDR P11473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13953945 0.83 KDM4E (0.39) CYP1A2CYP2A6RAB9ALMNAMAPT
SCHEMBL15178665 0.83 NPSR1 (0.43) APPCYP1A2CYP2A6RAB9ALMNA
SCHEMBL8185714 0.81 APP (0.40) APPCYP1A2CYP2A6RAB9ALMNA
SCHEMBL8189124 0.81 APP (0.40) APPCYP1A2CYP2A6RAB9ALMNA
SCHEMBL12055280 0.79 MAPT (0.39) APPCYP1A2CYP2A6RAB9ALMNA
SCHEMBL12774973 0.79 APP (0.39) APPCYP1A2CYP2A6HSD17B1HSD17B2
SCHEMBL8139709 0.77 CYP1A2 (0.42) CYP1A2CYP2A6HSD17B1HSD17B2RAB9A
SCHEMBL8273091 0.75 RAB9A (0.41) APPCYP1A2CYP2A6RAB9ALMNA
SCHEMBL8272622 0.74 GRM1 (0.38) APPRAB9ALMNAMAPTSENP7
SCHEMBL12335705 0.74 ACP1 (0.44) APPCYP1A2HSD17B1HSD17B2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2909205-B1 9-METHYL SUBSTITUTED HEXADECAHYDROCYCLOPROPA(E)PYRROLO(1,2-A)(1,4)DIAZACYCLOPENTADECINYL CARBAMATE DERIVATIVES AS NON-STRUCTURAL 3 (NS3) PROTEASE INHIBITORS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS BRISTOL MYERS SQUIBB CO (US) 2016-11-23 EP disclosed
EP-2033654-B1 Process for resolving a mixture of alkyl ester enantiomers using an enzyme BRISTOL MYERS SQUIBB CO (US) 2012-05-16 EP disclosed
EP-2033654-A1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus Bristol-Myers Squibb Company (US) 2009-03-11 EP disclosed
EP-1629000-B1 MACROCYCLIC ISOQUINOLINE PEPTIDE INHIBITORS OF HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2009-02-18 EP disclosed